We are live on
!
Find out more
LP
Lloyd Park Portfolio holdings
AUM
$81M
1-Year Est. Return
14.95%
This Fund
S&P 500
This Quarter
Est. Return
-16.45%
1 Year Est. Return
-14.95%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$95.6M
AUM Growth
+$4.95M
(+5.5%)
Cap. Flow
+$21.6M
Cap. Flow
% of AUM
22.56%
Top 10 Holdings %
Top 10 Hldgs %
51.11%
Holding
92
New
37
Increased
27
Reduced
4
Closed
12
Avg Time Held
1.1
quarters
Top 10 Avg Time Held
1.2
quarters
Top 20 Avg Time Held
1
quarter
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$6.96M |
| 2 |
Costco
COST
|
+$3.74M |
| 3 |
Warner Bros
WBD
|
+$2M |
| 4 |
Apollo Global Management
APO
|
+$1.82M |
| 5 |
Vanguard Long-Term Corporate Bond ETF
VCLT
|
+$1.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$2.26M |
| 2 |
Procter & Gamble
PG
|
+$2M |
| 3 |
Freeport-McMoran
FCX
|
+$1.99M |
| 4 |
iShares Russell 2000 Value ETF
IWN
|
+$1.97M |
| 5 |
Crown Holdings
CCK
|
+$1.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.56% |
| 2 | Technology | 17.87% |
| 3 | Financials | 17.79% |
| 4 | Consumer Staples | 9.25% |
| 5 | Healthcare | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Vertex Pharmaceuticals
VRTX
$130B
| $447K | 0.47% |
1,586
| – | – |
2021 Q4
2 quarters
|
|
52
Alnylam Pharmaceuticals
ALNY
$30.8B
| $438K | 0.46% |
3,000
| – | – |
2021 Q4
2 quarters
|
|
53
Labcorp
LH
$25.6B
| $400K | 0.42% |
1,985
+6
| +0.3% | +$1.28K |
2021 Q4
2 quarters
|
|
54
Nuveen Floating Rate Income Fund
JFR
$1.19B
| $388K | 0.41% |
+46,217
| New | +$419K |
2022 Q2
0 quarters
|
|
55
Tesla
TSLA
$1.5T
| $387K | 0.4% |
1,725
| – | – |
2021 Q4
2 quarters
|
|
56
Invesco QQQ Trust
QQQ
$499B
| $385K | 0.4% |
+1,375
| New | +$427K |
2022 Q2
0 quarters
|
|
57
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.32B
| $380K | 0.4% |
+28,818
| New | +$390K |
2022 Q2
0 quarters
|
|
58
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
$482M
| $380K | 0.4% |
+36,100
| New | +$396K |
2022 Q2
0 quarters
|
|
59
DELISTED
Exact Sciences
EXAS
| $355K | 0.37% |
9,000
| – | – |
2021 Q4
2 quarters
|
|
60
BlackRock Core Bond Trust
BHK
$593M
| $346K | 0.36% |
+30,565
| New | +$362K |
2022 Q2
0 quarters
|
|
61
Avista
AVA
$2.99B
| $321K | 0.34% |
7,373
+80
| +1% | +$3.44K |
2021 Q4
2 quarters
|
|
62
iShares Preferred and Income Securities ETF
PFF
$12.2B
| $292K | 0.31% |
+8,867
| New | +$300K |
2022 Q2
0 quarters
|
|
63
Franklin Master Intermediate Income Trust
PIM
$146M
| $285K | 0.3% |
+83,161
| New | +$288K |
2022 Q2
0 quarters
|
|
64
Yum China
YUMC
$14.3B
| $272K | 0.28% |
5,617
| – | – |
2021 Q4
2 quarters
|
|
65
Western Asset Municipal High Income Fund
MHF
$138M
| $268K | 0.28% |
+40,788
| New | +$274K |
2022 Q2
0 quarters
|
|
66
Eaton Vance Short Duration Diversified Income Fund
EVG
$140M
| $266K | 0.28% |
+24,769
| New | +$266K |
2022 Q2
0 quarters
|
|
67
Vanguard FTSE Emerging Markets ETF
VWO
$126B
| $262K | 0.27% |
6,283
+45
| +0.7% | +$1.94K |
2021 Q4
2 quarters
|
|
68
Nuveen Credit Strategies Income Fund
JQC
$684M
| $255K | 0.27% |
+48,655
| New | +$274K |
2022 Q2
0 quarters
|
|
69
BlackRock Credit Allocation Income Trust
BTZ
$881M
| $227K | 0.24% |
+20,800
| New | +$237K |
2022 Q2
0 quarters
|
|
|
JRO
70
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
| $212K | 0.22% |
+25,761
| New | +$231K |
2022 Q2
0 quarters
|
|
71
DELISTED
BlackRock Municipal Income Fund, Inc.
MUI
| $202K | 0.21% |
+16,876
| New | +$206K |
2022 Q2
0 quarters
|
|
72
Franklin Managed Municipal Income Trust
PMM
$250M
| $180K | 0.19% |
+27,005
| New | +$178K |
2022 Q2
0 quarters
|
|
73
PIMCO Income Strategy Fund
PFL
$344M
| $171K | 0.18% |
+18,825
| New | +$177K |
2022 Q2
0 quarters
|
|
74
PIMCO Income Strategy Fund II
PFN
$623M
| $171K | 0.18% |
+21,427
| New | +$173K |
2022 Q2
0 quarters
|
|
75
AllianceBernstein Global High Income Fund
AWF
$824M
| $144K | 0.15% |
+14,741
| New | +$149K |
2022 Q2
0 quarters
|
|
Similar funds
BRC
MCAU
NCA
TCM
PIMH
GI
EFEM
RA
Lloyd Park's Q2 2022 Portfolio in Review
As of Q2 2022, Lloyd Park held 92 positions worth $95.6M, up 5.5% from $90.7M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Lloyd Park deployed $21.6M of net new capital in Q2 2022, opening 37 new positions and adding to 27 existing holdings. Its largest new stake was Warner Bros: 107,840 shares worth $1.45M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 22% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Procter & Gamble, an estimated $2M trimmed.
- Lloyd Park's largest Q2 2022 buy was Warner Bros: 107,840 shares worth $1.45M.
- Lloyd Park added most to CME Group in Q2 2022, an estimated $6.96M increase.
- Lloyd Park's biggest Q2 2022 reduction was Procter & Gamble, cutting an estimated $2M.
- Lloyd Park fully exited Danaher in Q2 2022, selling an estimated $2.26M.
- Lloyd Park's ten largest holdings make up 51% of its $95.6M portfolio in Q2 2022.
- Lloyd Park opened 37 new positions and closed 12 in Q2 2022.
- Lloyd Park's portfolio value rose 5.5% quarter-over-quarter to $95.6M.
Based on Lloyd Park's 13F filing for Q2 2022, filed 9 Aug 2022.